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a b s t r a c t
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a multifunctional protein with diverse biologi-
cal functions in human cells. In bacteria, moonlighting GAPDH functions have only been described for the
secreted protein in pathogens or probiotics. At the intracellular level, we previously reported the interac-
tion of Escherichia coli GAPDH with phosphoglycolate phosphatase, a protein involved in the metabolism
of the DNA repair product 2-phosphoglycolate, thus suggesting a putative role of GAPDH in DNA repair
processes. Here, we provide evidence that GAPDH is required for the efﬁcient repair of DNA lesions in
E. coli.We show that GAPDH-deﬁcient cells aremore sensitive to bleomycin ormethylmethanesulfonate.
In cells challenged with these genotoxic agents, GAPDH deﬁciency results in reduced cell viability and
ﬁlamentous growth. In addition, the gapA knockoutmutant accumulates a higher number of spontaneous
abasic sites and displays higher spontaneous mutation frequencies than the parental strain. Pull-down
experiments in different genetic backgrounds show interaction betweenGAPDHand enzymes of the baseracil DNA glycosylase excision repair pathway, namely the AP-endonuclease Endo IV and uracil DNA glycosylase. This ﬁnding
suggests that GAPDH is a component of a protein complex dedicated to the maintenance of genomic DNA
integrity. Our results also show interaction of GAPDH with the single-stranded DNA binding protein.
This interaction may recruit GAPDH to the repair sites and implicates GAPDH in DNA repair pathways
activated by profuse DNA damage, such as homologous recombination or the SOS response.
ublis© 2015 The Authors. P
. Introduction
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, EC
.2.1.12), a key glycolytic enzyme, is a moonlighting protein with
dditional functions that are unrelated to its original metabolic
ole. The multifunctionality of GAPDH is extensively documented
nhuman cells,where it is involved innumerousprocesses (Sirover,
011). The various moonlighting functions of GAPDH depend on
Abbreviations: AP sites, abasic sites (apurinic/apyrimidinic); BER, base excision
epair; BM, bleomycin; CAA, casein acid hydrolysate; CFUs, colony-forming units;
ndo, endonuclease; Exo, exonuclease; GAPDH, glyceraldehyde-3-phosphate dehy-
rogenase; Gph, phosphoglycolate phosphatase; GST, glutathione-S-transferase;
R, homologous recombination; IPTG, isopropyl -d-1-thiogalactopyranoside;
B, Luria-Bertani broth; MMS, methyl methanesulfonate; NIR, nucleotide inci-
ion repair; NTA, nitrilotriacetic acid; PTasRNA, paired termini antisense RNA;
ifampicin, Rif; SSB, single-stranded DNA binding protein; SM, minimal medium;
DG, uracil DNA glycosylase.
∗ Corresponding author. Tel.: +34 934034496; fax: +34 934024520.
E-mail address: lbaldoma@ub.edu (L. Baldomà).
1 These authors contributed equally to this work.
ttp://dx.doi.org/10.1016/j.biocel.2015.01.008
357-2725/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article unhed by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
speciﬁc post-translational modiﬁcations, oligomeric state and/or
subcellular localization, which determine the binding partners
(Copley, 2012; Sirover, 2005, 2011). Each function requires binding
into speciﬁc protein complexes.
In bacteria, GAPDH moonlighting functions are mainly associ-
ated with its extracellular location. This protein is secreted and
exposed on the bacterial surface, enabling pathogens to colo-
nize and manipulate host cells (Pancholi and Chhatwal, 2003). In
enteropathogenic and enterohemorrhagic Escherichia coli, secreted
GAPDH interacts with human plasminogen and ﬁbrinogen and
remains associated with Caco-2 cells upon infection (Egea et al.,
2007). In addition, the secreted protein can act as a target of oxi-
dation and protect bacteria against the host oxidative response
(Aguilera et al., 2009). GAPDH has also been identiﬁed in the
secretome of probiotic strains (Aguilera et al., 2012; Sánchez
et al., 2009a) and shown to interact with mucin, thus contribut-
ing to intestinal colonization (Kinoshita et al., 2008; Sánchez et al.,
2009b).
Studies dealing with new GAPDH intracellular functions are
scarce in bacteria. Following a proteomic approach aimed at iden-
tifying proteins that interact with GAPDH in E. coli, we identiﬁed
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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hosphoglycolate phosphatase (Gph) (Ferreira et al., 2013). This
nzyme is involved in the metabolism of 2-phosphoglycolate
ormed in the DNA repair of 3′-phosphoglycolate ends generated
y bleomycin (BM) (Pellicer et al., 2003). Interaction between Gph
nd GAPDH increases in BM-treated cells, thus implicating GAPDH
n processes linked to DNA repair (Ferreira et al., 2013).
Involvement of GAPDH in the repair of BM-generated DNA
esionshas been reported inhumancells. GAPDH interactswith and
odulates the activity of endonuclease APE1, an enzyme involved
n the repair of abasic sites (AP sites) (Azam et al., 2008). AP sites
re generated when cells are exposed to genotoxic agents such as
M or alkylating agents like methyl methanesulfonate (MMS).
BM is a radiomimetic drug that promotes site-speciﬁc free rad-
cal attack on deoxyribose moieties, generating AP sites as well as
ingle- and double-strand breaks with mainly 3′-phosphoglycolate
nds (Povirk, 1996). The AP sites are repaired through the
ase-excision repair (BER) pathway by the sequential action of
P-endonucleases (Endo IV and Exo III), DNA polymerase I and
NA ligase (Morita et al., 2010). The 3′-phosphoglycolate ends
re removed as free 2-phosphoglycolate by Endo IV and Exo III
efore the strand breaks are repaired by the homologous recom-
ination pathway (Fig. S1). MMS mainly produces methylations in
everal positions of purine bases (Sedgwick, 2004; Sedgwick et al.,
007). The major base modiﬁcations are N7-methylguanine or N3-
ethyladenine. These lesions are an important source of AP sites,
hich are mainly generated during their repair by the DNA glyco-
ylases Tag or/and AlkA. O6-methylated guanines, also produced as
inor products, are directly repaired by the alkyltransferases Ogt
nd Ada (Fig. S1).
The BER pathway is also involved in the processing of AP sites
enerated during the repair of spontaneous DNA lesions. One
ource of such AP sites is the action of uracil DNA glycosylases
UDG). These enzymes remove uracil present in DNA either as
product of cytosine deamination or mistaken incorporation of
UMP during replication (Morita et al., 2010).
Here, we report that E. coli GAPDH is required for the efﬁcient
epair of DNA lesions induced by BM or MMS, as well as of sponta-
eous AP sites. Deﬁciency in GAPDH leads to increased sensitivity
o these agents and changes in cell morphology, which are con-
istent with the induction of the SOS response. Using pull-down
ssays with recombinant proteins expressed in different mutant
ackgrounds,we show interaction betweenGAPDHand proteins of
he BER pathway, speciﬁcally Endo IV and UDG, as well as between
APDH and SSB.
. Materials and methods
.1. Bacterial strains, growth conditions and preparation of cell
xtracts
The E. coli strains and plasmids used are listed in Table 1. Bac-
erial cells were routinely grown at 37 ◦C in Luria-Bertani broth
LB), except the gapA mutant strains, which were grown in min-
mal medium (SM) with malate and glycerol as carbon sources
Ganter and Plückthun, 1990). In drug challenge experiments,
ells were grown in SM with 0.5% casein acid hydrolysate (CAA)
s carbon source (Pellicer et al., 2003). For gapA mutants, this
ediumwassupplementedwith20mMglycerolGrowthwasmon-
tored by measuring the optical density at 600nm (OD600). When
equired, tetracycline (12.5g/ml), chloramphenicol (30g/ml),
mpicillin (100g/ml) or rifampicin (Rif) (50g/ml) was added to
he medium. Genetic crosses were performed by P1 transduction
Miller, 1992).
To construct strain MC4100 gapA, the gapA::tet mutation
resent in strain W3CG was transduced into strain MC4100. Sincehemistry & Cell Biology 60 (2015) 202–212 203
GAPDH-deﬁcient mutants do not grow in LB, strain W3CG was
ﬁrst transformed with plasmid pBAD-gapA (Ferreira et al., 2013).
Expression of GAPDH-V5 from this recombinant plasmid restored
GAPDH deﬁciency and allowed strain W3GC to grow in this
medium. The P1 lysate obtained from this transformed strain was
used to infect strain MC4100, and transductants were selected
on SM-malate-glycerol plates containing tetracycline. The correct
insertion of gapA::tet in the transductants was assessed by neg-
ative growth on SM-glucose plates. One of these transductants,
strain MC4100 gapA, was selected and GAPDH deﬁciency was
demonstrated by enzymatic activity and western blot analysis.
Cell extracts were obtained by sonic disruption of bacterial cells
as described previously (Aguilera et al., 2012).
2.2. Recombinant DNA techniques
Bacterial genomicDNAwas obtained using theWizardGenomic
DNA puriﬁcation kit (Promega), and plasmid DNA was prepared
using the Wizard Plus SV Midipreps DNA puriﬁcation system
(Promega). DNA manipulations were performed essentially as
described elsewhere (Sambrook and Rusell, 2001). DNA fragments
wereampliﬁedbyPCRusingE. coli chromosomalDNAasa template.
Primers used in this work are listed in Table S1.
To obtain recombinant GST-Ogt, the ogt gene was ampliﬁed by
PCRandcloned intoBamHI/EcoRI restriction sitesof vectorpGEX-3x
(Amersham) yielding plasmid pGEX-Ogt. Recombinant His6-Exo III
was produced from plasmid pQE30-XthA, which was constructed
by cloning the PCR-ampliﬁed xthA gene into BamHI/HindIII restric-
tion sites of vector pQE30 (Qiagen).
2.3. Cloning of gapA antisense RNA (asRNA) sequences into
IPTG-inducible vectors for conditional gene silencing
To obtain gapA asRNA, we used a collection of IPTG-inducible
expression vectors that allow conditional expression of the asRNA
with paired termini (PTasRNA), thus conferring great RNA stabil-
ity and high silencing efﬁcacy (Nakashima et al., 2006; Nakashima
and Tamura, 2009). Two sets of oligonucleotides were used to
amplify two different gapA asRNA sequences (Table S1). Both asR-
NAs were complementary to the genomic region that encompasses
the gapA ribosome binding site and the start codon. The ampli-
ﬁed PCR products were cloned into the NcoI/XhoI restriction sites
of the PTasRNA vectors pHN1009, pHN678 or pHN1242, which
differ in their copy number (Table 1). Strain XL1-Blue was used
for cloning and plasmid preparation. Strain MC4100 was used as
a host for expressing gapA PTasRNA in silencing experiments. To
this end, cells of strain MC4100 bearing the gapA PTasRNA con-
structswere grownovernight in the absence of IPTG. These cultures
were diluted 1:200 with fresh medium containing 1mM IPTG and
cultured tomid- to late-logarithmic phase depending on the exper-
iment. Knockdown GAPDH expression under these conditions was
assessed by measurement of enzyme activity and western blot
analysis in cell extracts.
2.4. Expression and puriﬁcation of recombinant proteins
Recombinant wild-type GAPDH and the derived C149A and
C153Amutantswere expressed and puriﬁed using the glutathione-
S-transferase (GST) gene fusion system with recognition sites for
factor Xa cleavage, as described elsewhere (Egea et al., 2007;
Aguilera et al., 2009). This expression system was also used to
obtain recombinantOgt. For this protein, induction andpuriﬁcation
conditions were the same as those described for GST-GAPDH.
Proteins Endo IV (Nfo), single-stranded DNA binding pro-
tein (SSB), 6-methylguanine-DNA methyltransferase (Ada), 3-
methyladenine DNA glycosylases I (Tag) and II (AlkA) and uracil
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Table 1
Strains and plasmids used in this study.
Strain or plasmid Genotype or description Source or reference
E. coli strains
XL1Blue recA1 lac endA1 gyrA96 thi hsdR17 supE44 relA1 (F’ proAB lacIq lacZM15 Tn10) Stratagene
BL21(DE3) F− ompT hsd(rB−mB−)gal Amersham
M15[pREP4] F− Nals Strs rifs lac− mtl− recA− [pREP4 Kanr] Qiagen
AG1 (ME5053) recA1 endA1 gyrA96 thi-1 hsdR17(rK−mK−) supE44 realA1 (host cell for pCA24N) NBRP; Kitagawa et al. (2005)
W3CG F−  − thyA36 deoC2 IN(rrnD-rrnE) (W3110)gapA::tet supE Ganter and Plückthun (1990)
MC4100 F− araD(argF-lac) rpsL(Strr) relA ﬁhD deoC ptsF rbs Casadaban, 1976
MC4100gapA MC4100gapA::tet This study
MG1655 ung::kan MG1655 ung::kan Bharti and Varshney (2010)
MG1655nfo::cm MG1655nfo::cm Bjedov et al. (2007)
Plasmids
pGEX.3x Vector for expression of N-terminal GST-tag proteins, Apr Amersham
pGEX-GapA pGEX-3x expressing GST-GAPDH, Apr Egea et al. (2007)
pGEX-GapA.C149A pGEX-3x expressing GST-GAPDH C149A mutant, Apr Aguilera et al. (2009)
pGEX-GapA.C153A pGEX-3x expressing GST-GAPDH C153A mutant, Apr Aguilera et al. (2009)
pGEX-Ogt Gene ogt cloned in pGEX-3x for expression of GST-Ogt This study
pBAD-GapA Gene gapA cloned in pBAD-TOPO for expression of GAPDH-V5 Ferreira et al. (2013)
pQE30 Vector for expression of N-terminal His6-tag proteins, Apr Qiagen
pQE30-XthA pQE30 expressing His6-ExoIII, Apr This study
JW2146 ASKA clone for expression of His6-EndoIV (nfo gene cloned in pCA24N), Cmr NBRP; Kitagawa et al. (2005)
JW4020 ASKA clone for expression of His6-SSB (Ssb gene cloned in pCA24N), Cmr NBRP; Kitagawa et al. (2005)
JW3518 ASKA clone for expression of His6-Tag (tag gene cloned in pCA24N), Cmr NBRP; Kitagawa et al. (2005)
JW2201 ASKA clone for expression of His6-Ada (ada gene cloned in pCA24N), Cmr NBRP; Kitagawa et al. (2005)
JW2053 ASKA clone for expression of His6-AlkA (alkA gene cloned in pCA24N), Cmr NBRP; Kitagawa et al. (2005)
pHN678 Vector for expression of PT-asRNA, medium copy number (pACYC ori), Cmr Nakashima and Tamura (2009)
pHN1009 Vector for expression of PT-asRNA, high copy number (pBR322 ori), Apr Nakashima and Tamura (2009)
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pHN1009-1 pHN1009 expressing gapA-asRNA (−76/+8
pHN1009-2 pHN1009 expressing gapA-asRNA (−97/+7
NA glycosylase (UDG) were expressed as His6-tagged proteins
rom the ASKA clones JW2146, JW4020, JW2201, JW3518, JW2053
nd JW2564, respectively (NBRP, E. coli StrainNational BioResource
roject) (Kitagawa et al., 2005). The host strain for ASKA clones
as AG1 (ME5053) (Table 1). The recombinant protein His6-ExoIII
as expressed from plasmid pQE30-XthA in strain M15 [pREP4]
Table 1). Expression of the His-tagged proteins was induced by
ddition of 0.1mMIPTG to exponential growncultures, followedby
vernight incubation at 20 ◦C. Proteins were puriﬁed under native
onditions with Ni2+-nitrilotriacetic acid (NTA) resin (Qiagen), as
escribed elsewhere (Kitagawa et al., 2005).
.5. Pull-down assays and immunoblotting analysis
Pull-down assays based on His6-tagged recombinant proteins
ere performed essentially as described previously (Aguilera et al.,
012). GST pull-down assays were performed to analyze interac-
ion of GST-GAPDH (either the wild-type protein or the derived
149A or C153Amutants)withHis6-Endo IV. In these experiments,
xpression and binding of GST-GAPDH to a glutathione-Sepharose
B column was carried out as previously described (Egea et al.,
007; Aguilera et al., 2009). At this point, column-bound GST-
APDH, equilibrated in PBS buffer, was incubated for 30min at
◦C with 0.5ml of a cell extract (10mg/ml) obtained in PBS buffer
rom AG1 cells expressing His6-EndoIV. After extensive washing,
ecombinant GAPDH and interacting proteins were eluted with
lutathione elution buffer and analyzed by SDS–PAGE (Laemmli,
970) followed by immunoblotting analysis with anti-His antibod-
es. Pull-down experiments with the GST-tag were performed in
arallel as a negative control.
Western blot analysis was performed as described previously
Egea et al., 2007; Aguilera et al., 2012)..6. Drug exposure and cell survival
MC4100 cells bearing plasmid pHN1009-1 for gapA silencing or
he vector pHN1009 as a control (Table 1) were grown aerobicallymber (pSC101 ori), Kan Nakashima and Tamura (2009)
r This study
r This study
to mid-exponential phase (OD600 of 0.5) in SM-0.5% CAA supple-
mentedwith ampicillin and 1mM IPTG. At this point, cultureswere
challenged with BM (10g/ml in the presence of 50M FeSO4),
MMS (10mM) or H2O2 (2.5mM). At different times, aliquots of
the cultures were collected, washed twice with SM and processed
for analysis. Survival was estimated by diluting cells in SM, fol-
lowed by plating on LB-ampicillin plates to determine the number
of colony forming units (CFUs). GAPDH activity was determined
in cell extracts. In drug-challenge experiments using the knockout
mutant strain MC4100 gapA, the growth medium was SM-0.5%
CAA supplemented with 20mM glycerol and doses of BM and MMS
were 5g/ml and 5mM, respectively. Bleomycin sulfate (Almirall
Prodesfarma, Barcelona, Spain) was freshly prepared with 50mM
phosphate buffer (pH 7.5) and FeSO4 solutions were prepared
immediately before use.
2.7. Microscopic observations
To examine the morphology of growing cells upon drug expo-
sure, liquid cultureswere processed as described above and treated
with BM (10g/ml) or MMS (10mM) for 10 and 20min. Then,
cultures were washed with PBS, suspended in fresh medium and
incubated aerobically at 37 ◦C to re-start growth. After 3h, aliquots
were taken, spread onto glass slides, ﬁxed, stained with methy-
lene blue and examined under a light microscope (Leica DM1000)
with a 100× objective lens. Non-treated bacteria were processed
in parallel as a control.
2.8. Enzyme activities
GAPDH activity was measured following the reduction of NAD+
to NADH at 340nm (Pancholi and Fischetti, 1992).
Endo IV activity was assayed coupled to uracil-DNA
glycosylase (UDG) using a 40-mer duplex DNA substrate
containing a U-G mismatch (U19.G) as described else-
where (Shatilla and Ramotar, 2002; Bulgar et al., 2012). This
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sDNA oligonucleotide was prepared by mixing equimolar
uantities of the two complementary oligonucleotides 5′(DIG)-
TAAAACGACGGCCAGTGUATT CGAGCTCGGTACCCGGGG-3′ and
′(DIG)-CCCCGGGTACCGAGCTCGAATGCACTGGCCGTCGTTTTAC-3′,
oth 5′-end labeled with digoxygenin (DIG) (Sigma Genosys).
he mixture was heated to 80 ◦C for 30min and then allowed
o cool slowly overnight at room temperature. To create an AP
ite, the DIG-labeled duplex DNA (20pmol) was incubated with
ommercial UDG (Sigma Aldrich) (2 units) at 37 ◦C for 1h in 20mM
ris–HCl buffer (pH 8.0) containing 1mM EDTA, 1mM DTT and
0mM NaCl in a ﬁnal volume of 20l. Aliquots of 4l containing
he AP-site substrate were incubated with Endo IV (New England
iolabs) (2 units) at 37 ◦C for 30min in 50mM Tris–HCl buffer (pH
.0) containing 1mM MgCl2, 0.1mM DTT and 10mM NaCl in a ﬁnal
olume of 20l. Reactions were stopped by transferring tubes
n ice followed by the addition of an equal volume of formamide
oading buffer (76% formamide, 0.3% bromophenol blue, 0.3%
ylene cyanole and 10mM EDTA) and incubation at 65 ◦C for
min. Reaction products (20-mer fragments) were resolved by
lectrophoresis on denaturing 10% polyacrylamide/7M urea gel
nd blotted onto a nylonmembrane using a Bio-Rad electroblotting
ystem. Detection of DIG-labeled DNA fragments was carried out
sing the enzyme immunoassay DIG Luminescent Detection Kit
Roche). Reactions omitting UDG or Endo IV were performed in
arallel as a control. When indicated, puriﬁed GAPDH (10g) was
dded instead of UDG. When used, the UDG inhibitor Ugi (New
ngland Biolabs) was added to the reaction mixture containing
DG and buffer. After 10-min pre-incubation at 37 ◦C, reaction was
tarted by the addition of the DIG-labeled duplex DNA substrate.
.9. Quantiﬁcation of AP sites in genomic DNA
Bacterial cultures were grown aerobically at 37 ◦C to an OD600
f 0.5. Cells were collected by centrifugation and subjected to DNA
xtraction using theDNAzol® Reagent (Invitrogen). DNAwas quan-
iﬁed with a NanoDrop ND-100 Spectrophotometer (NanoDrop
echnologies). Quantiﬁcation of AP sites was performed by using
heOxiselectTM OxidativeDNADamageQuantiﬁcationKit (Cell Bio-
abs) according to the manufacturer’s protocol.
The presence of AP sites in DNA was also evaluated by means
f their susceptibility to alkaline pH as described elsewhere (Bharti
nd Varshney, 2010). Genomic DNA (1g) was treated with 0.1N
aOH, heated at 90 ◦C for 10min and analyzed by electrophoresis
n 1% agarose gel containing ethidium bromide.
.10. Determination of mutation frequencies
Five independent cultures of each strainwere grown in SM-0.5%
AA-20mMglycerol to anOD600 of 0.4–0.5. At this point, cellswere
arvested and resuspended in 100l of the same culture medium,
latedonSM-CAA-glycerol agar containingRif (50g/ml) and incu-
ated overnight at 37 ◦C in dark. Rif-resistant colonies were scored.
or each sample, the total number of viable cells was estimated
y serial dilution followed by colony counting on SM-CAA-glycerol
lates.
.11. Quantiﬁcation of cellular ATP levelsBacterial cells were grown aerobically to an OD600 of 0.5 and
ellular ATP concentrations were measured using the ATP biolu-
inescence Assay Kit HS II (Roche) according to manufacturer’s
nstructions.hemistry & Cell Biology 60 (2015) 202–212 205
3. Results
3.1. Sensitivity of GAPDH-deﬁcient cells to DNA-damaging agents
To test whether E. coli GAPDH performs a moonlighting func-
tion in DNA repair, we examined the sensitivity of the gapA null
mutant (MC4100 gapA) to agents that damage DNA, speciﬁcally
BMandMMS. Theparental strainMC4100wasprocessed inparallel
as a control. Drug treatment was performed in cells grown aerobi-
cally tomid-exponential phase in SM-0.5% CAA supplementedwith
20mM glycerol. In this medium, no differences in cell growth were
observed between the gapA mutant and its parental strain (Fig.
S2A). At different times of incubation with these compounds, cell
survival was evaluated. GAPDH-deﬁcient cells were more sensitive
than the wild-type cells to both BM and MMS (Fig. 1).
Since GAPDH has a central role in bacterial metabolism, we
approached a parallel analysis using E. coli cells with reduced
GAPDH levels to avoid possible side effects of complete GAPDH
deﬁciency. To knockdown GAPDH levels, we prepared several
constructs (high-,medium-and low-copynumber) that allow IPTG-
inducible expression of two gapA asRNA, (−76/+86) or (−97/+70).
The effect of gapA asRNA expression on cell growth and GAPDH
protein levels was analyzed in LB-IPTG cultures of transformed
MC4100 cells. From this screening, we selected the construct
pHN1009-1, which expressed the gapA asRNA (−76/+86) from the
high copy number vector pHN1009 (Fig. S3). Before approaching
drug challenge experiments, we conﬁrmed that expression of gapA
asRNA from pHN1009-1 did not impair growth of strain MC4100 in
SM-0.5% CAA. Under these conditions, the level of GAPDH protein,
monitored by enzyme activity and immunoblotting, was reduced
by nearly 90%, as compared with cells bearing the vector pHN1009
(Fig. S2). The gapA-silenced cells (MC4100 bearing pHN1009-1)
were challenged with BM or MMS, and also with H2O2. Cell viabil-
ity was estimated after different times of incubation and compared
with that of cells bearing vector pHN1009. Results showed that
gapA-silenced cells were more sensitive than wild-type cells to BM
and MMS, especially at incubation times up to 60min (Fig. 2A).
In contrast, no differences in cell survival were observed between
wild-type or gapA-silenced cells treated with H2O2 at any incu-
bation time (Fig. 2B). H2O2 inhibits GAPDH activity by oxidation of
catalytic C149,which formsadisulphideboundwithC153 (Leichert
et al., 2008). Consistently,GAPDH levels ofMC4100 (pHN1009) cells
treated with H2O2 were signiﬁcantly reduced, being around 15% of
that of the non-treated cells (Fig. 2C). However, exposure to BM or
MMS did not modify GAPDH activity. Wild-type as well as silenced
cells displayed similar GAPDH activity levels to the correspond-
ing non-treated controls (Fig. 2C), which indicated that neither
genotoxic agent oxidizes the catalytic C149 residue. This observa-
tion is compatible with the action mechanism of these compounds
(Sedgwick et al., 2007; Povirk, 1996). Overall, these results sug-
gested that the role of GAPDH in DNA repair may depend on the
reduced state of C149.
3.2. Filamentous growth of GAPDH-deﬁcient cells after BM or
MMS treatment
The SOS response is a bacterial defense system activated under
conditions of extensiveDNAdamage. Induction of the SOS response
results in ﬁlamentous growth due to the expression of gene
sulA, which encodes an inhibitor protein of cell division. Under
these conditions, delay in cell division allows for DNA repair
after treatment with DNA-damaging agents (Janion et al., 2003;
Janion, 2008). Since gapA-knockout and gapA-silenced cells were
more sensitive to BM and MMS than the wild-type strains, we
analyzed cell morphology at 3-h growth in fresh medium after
10- or 20-min treatment with these DNA-damaging agents. After
206 E. Ferreira et al. / The International Journal of Biochemistry & Cell Biology 60 (2015) 202–212
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Fig. 1. Effect of GAPDH deﬁciency on cell survival after treatment with DNA-damaging agents. Cells of MC4100gapA (squares) and its parental strain MC4100 (triangles)
grown in SM-0.5% CAA+20mMglycerol to an OD600nm of 0.5were challengedwith 5mMMMSor 5g/ml BM-50Mde FeSO4. At the indicated times, aliquotswere collected
and monitored for cell survival. Values, given as the percentage of viable cells (CFUs on SM-CAA-glycerol plates) with respect to non-treated cells, are the mean± standard
deviation (SD) of three replicates. *P<0.05 compared to wild-type cells by ANOVA followed by Tukey’s test.
Fig. 2. Effect of gapA-silencing on cell survival after treatmentwithDNA-damaging agents. Control (pHN1009 in triangles) and gapA-silenced (pHN1009-1 in squares)MC4100
cells were challenged with: (A) 10g/ml BM-50M de FeSO or 10mM MMS and (B) 2.5mM H O . At the indicated times, aliquots were collected and monitored for cell
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urvival. Values are given as the percentage of viable cells (CFUs on SM-CAA ampic
ell extracts obtained from silenced cells bearing pHN1009-1 (black bars) or from c
gents. The values are the mean± standard deviation (SD) of three replicates. *P<0
-h recovery, the wild-type cells displayed normal growth while
APDH-deﬁcient cells formed ﬁlaments when treated either with
MS or BM (Fig. 3). These results are compatible with involvement
f GAPDH in the repair of MMS- and BM-generated DNA damage
n E. coli.
AP sites are commonly formed in response to both genotoxic
gents. To analyze the level of unrepaired DNA in wild-type and
gapA cells after 3-h recovery from 10mM MMS-treatment, we
erformed a genomic degradation assay (Bharti and Varshney,
010). This protocol was based on the susceptibility of AP sites
o alkaline pH. Samples obtained before and after 20-min treat-
entwere processed in parallel for comparison. GenomicDNAwas2 2
lates) with respect to non-treated cells. (C) Values of GAPDH activity measured in
aring pHN1009 vector (gray bars) after 2-h treatment with the indicated genotoxic
mpared to wild-type cells by ANOVA followed by Tukey’s test.
treated with NaOH and heated to 90 ◦C. The migration rate of the
denaturalized DNA species was evaluated by gel electrophoresis
(Fig. 4). Assays performed with DNA samples obtained after 20min
treatment resulted in the formation of fast-migrating degradation
products in both cells (Fig. 4, lanes 2 and 5). After 3-h recovery in
freshmedium,most of the denaturedDNA fromstrainMC4100 cor-
responded tohighmolecularweight species (Fig. 4, lane3),whereas
in the case of thegapA mutant, these species were less abundant.
In addition, deﬁned degradation fragments were more apparent
(Fig. 4, lane 6). These results were consistent with the presence of
more unrepaired DNA lesions in the gapA null mutant than in the
wild-type strain.
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F M. Bacteria were treated with MMS (10mM) or BM (10g/ml) for 10 or 20min, washed
a e exposure to these DNA-damaging agents. Bar =10m.
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Table 2
Effect of GAPDH deﬁciency on the repair of spontaneous DNA lesions.ig. 3. Filamentous growth of GAPDH-deﬁcient cells after treatment with MMS or B
nd further incubated in the growth medium for 3h. Raw 1 presents bacteria befor
.3. Accumulation of spontaneous AP sites in gapA knockout
utants
The alkali degradation assay performed with genomic DNA iso-
ated from cells before MMS addition (Fig. 4, lanes 1 and 4) showed
ig. 4. Genome degradation assays after alkaline treatment. Exponential cultures of
he indicated cellswere challengedwith 10mMMMS for 20min and let to recover in
resh medium as described in Fig. 3. DNA was isolated from cells before MMS treat-
ent (lanes 1 and 4), after MMS treatment (lanes 2 and 5) and after 3-h recovery
n fresh medium (lanes 3 and 6). (A) Genomic DNA (1g) was heated in the pres-
nce of NaOH and analyzed by electrophoresis on agarose gel containing ethidium
romide. Prominent DNA degradation fragments are indicated by asterisks. (B) For
ach condition, non-treated genomic DNA (1g) was resolved by electrophoresis
s a loading control.
Strain AP sites/
100,000bp
Mutation
frequency (×10−9)
Cellular ATP levels
(pmol/106 cells)
MC4100 8.5 ± 0.4 11.4 ± 3.1 4.1 ± 0.3
MC4100gapA 12.8 ± 0.8 54.2 ± 5.2 3.9 ± 0.2Cellswere grown in SM-0.5%CAA supplementedwith 20mMglycerol to anOD600 nm
of 0.5 and processed as described in Section 2 for each assay.
a minor amount of high-molecular mass products in DNA samples
from MC4100 gapA than the wild-type strain. This observation
suggested the presence of more spontaneous AP sites in the gapA
mutant DNA. In fact, quantiﬁcation of AP sites with a biotinylated
aldehyde-reactive probe, followed by biotin detection coupled to
streptavidin, showed a 1.5-fold increase in the number of sponta-
neous AP sites in the genomic DNA of the gapA null mutant when
compared to the parental strain (Table 2).
Since AP sites are mutagenic, we determined mutation fre-
quencies of wild-type MC4100 and MC4100 gapA by scoring
for Rif-resistant colonies on SM-0.5% CAA-20mM glycerol plates.
Consistently, the gapA mutant showed a 4.7-fold increase when
compared with the wild-type strain (Table 2). Under the growth
conditions used no differences in cellular ATP levels were observed
between the two strains (Table 2). Thus, inefﬁcient repair of spon-
taneous AP sites in the gapA mutant may not be attributed to a
reduced energy supply.3.4. GAPDH interacts with Endo IV and SSB
Since moonlighting functions of GAPDH may depend on its
ability to interact with other proteins and participate in protein
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Fig. 5. Pull-down experiments to analyze interaction of GAPDH with proteins involved in DNA repair. (A) Cell extracts obtained from induced cultures of strain AG1 bearing
the ASKA clone JW2146 (expressing His6-Endo IV), ASKA clone JW4020 (expressing His6-SSB) or pQE30-XthA (expressing His6-Exo III) were applied to a Ni2+-NTA column.
After extensive washing, elution of recombinant proteins was achieved with 300mM imidazole (elution buffer). As a control, a cell extract of the host cell AG1 was applied
to the Ni2+-NTA column and processed in parallel (right panel). Column fractions (FT: ﬂow-through; W: wash; E: elution) were analyzed either by Coomassie blue staining
(upper panels) or by western blot with anti-GAPDH antibodies. (B) Pull-down experiments to analyze interaction of GAPDH with UDG. The ASKA clone JW2564 (His6-UDG)
was expressed in an Endo IV-deﬁcient background (MG1655nfo::cm) as well as in the wild-type isogenic strain (MG1655) for comparison. Cell extracts were applied to a
Ni2+-NTA column and processed as described above.
Fig. 6. Analysis of GAPDH–Endo IV interaction. Cells extracts of strain MC4100 gapA expressing GST (as a control) or the indicated GST-GAPDH variants were applied to
Glutathione-Sepharose 4B columns to immobilize these recombinant proteins. After washing, a cell extract obtained from induced cells bearing the ASKA clone JW2146
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aexpressing His6-Endo IV) was passed over the columns. After extensive washing, th
ractions were analyzed either by Coomassie blue staining (upper panel) or by west
xpressing His6-Endo IV); FT2, second ﬂow-through (after applying the cell extract
omplexes dedicated to speciﬁc cellular functions, we next ana-
yzed whether GAPDH could interact with proteins of the BER
athway like theAP-endonucleases Endo IV andExo III, and the gly-
osylases Tag and AlkA. As ﬁlamentous growth of GAPDH-deﬁcient
ells revealed activation of the SOS response, we included SSB, an
ssential protein of this pathway that recruits and binds a vari-
ty of DNA repair proteins. In addition, we selected Ogt and Ada,
nzymes involved in the direct repair of O6-methylguanine lesions,
s Ogt had been identiﬁed as a putative binding partner of E. coli-tagged recombinant proteins were eluted with glutathione-elution buffer. Column
ot with anti-His antibodies. FT1, ﬁrst ﬂow-through (before applying the cell extract
ssing His6-Endo IV); W, ﬁnal wash of each step; E, eluted fraction.
GAPDH in large-scale protein interaction studies (Butland et al.,
2005). All these proteins were expressed as His6-tagged recom-
binant proteins and immobilized in a Ni2+-NTA resin, except Ogt,
which was expressed as GST-Ogt fusion protein and bound to a
glutathione-Sepharose 4B column. Pull-down experiments were
then performed to examine retention of chromosome-encoded
GAPDH. After extensive washing, GAPDH co-eluted with His6-SSB
and His6-Endo IV as detected by western blot probed with anti-
GAPDH speciﬁc antibody (Fig. 5A). No interaction between GAPDH
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ndExo III (Fig. 5A), Tag, AlkA, AdaorOgtwasdetected (not shown).
o conﬁrm interaction between GAPDH and Endo IV, pull-down
xperiments were performed using GST-GAPDH as bait. In this
ase, GST-GAPDH afﬁnity resin was incubated with a cell extract
btained fromE. coli cells overexpressingHis6-Endo IV. After exten-
ive washing, retention of this endonuclease on the resin was
ssessed bywestern blot analysis of the eluted fraction probedwith
nti-His antibodies. Immunodetection of a 31kDa protein in the
luted fraction from the GST-GAPDH afﬁnity resin, but not from
he control GST-bound resin, conﬁrmed GAPDH–Endo IV interac-
ion (Fig. 6). To testwhether this interaction depends on theGAPDH
esidues C149 or C153, pull-down experiments were performed
sing as bait the cysteine variants GST-GAPDH C149A or GST-
APDH C153A. To avoid interference with native GAPDH encoded
n the chromosome, expression of these recombinant GAPDH vari-
nts was approached in strain MC4100 gapA. Endo IV was also
etained and co-eluted with these GAPDH mutants (Fig. 6).
.5. GAPDH is a component of a multiprotein complex that
epairs DNA lesions through the BER pathway
A moonlighting function described for human GAPDH is its
ctivity as uracil-DNA glycosylase (UDG) (Meyer-Siegler et al.,
991). To analyze whether E. coli GAPDH displays UDG activity, a
′-DIG-labeled 40-mer double-stranded DNA substrate containing
U-G mismatch (U19.G) was incubated with puriﬁed E. coli GAPDH
Egeaet al., 2007) orwith commercialUDG (SigmaAldrich) as apos-
tive control. Removal of uracil from this substrate was measured
y coupling commercial E. coli Endo IV, which cleaves the AP-site-
ontaining strand in two 20-mer products. Visualization of the
0-mer product in reactions incubated with both commercial UDG
ndEndo IV validated the coupled enzyme assay (Fig. 7A, lane 4). As
xpected, this product was not observed when UDG was omitted
rom the reaction mixture (Fig. 7A, lane 2). However, in the assays
erformed in the absence of Endo IV, a faint band corresponding
o the 20-mer product was observed (Fig. 7A, lane 3), suggesting
hat the commercial UDG used here was contaminated with an AP-
ndonuclease, like Endo IV. Cleavage of the duplex oligonucleotide
ubstrate was also produced when recombinant GAPDH was used
nstead of commercial UDG, either in the presence or absence of
ndo IV. The same result was obtained with the two variants,
APDH-C149AorGAPDH-C153A (Fig. 7A, lanes5–10). These results
uggested either that E. coli GAPDH displays UDG activity or that
he UDG activity observed can be attributed to the chromosome-
ncoded UDG enzyme (ung gene product) that may co-purify with
ur recombinant GAPDH. To examine these two hypotheses, we
easured the GAPDH-associated UDG activity in the presence of
he Bacillus subtilis inhibitor Ugi, a protein that speciﬁcally inhibits
DGenzymes fromvarious organisms (Putnamet al., 1999; Shatilla
nd Ramotar, 2002). Pre-incubation of commercial UDG (as a con-
rol) or puriﬁed GAPDH with this inhibitor prevented cleavage
y Endo IV of the 40-mer substrate bearing U19.G mismatch, in
oth cases (Fig. 7B). These results suggested that the UDG activity
bserved with our GAPDH preparation may be due to the pres-
nce of chromosome-encoded UDG enzyme (Ung). To assess this
ypothesis, we transformed the mutant strain MG1655 ung::kan
ith plasmid pGEX-GapA to express recombinant GST-GAPDH in a
DG-deﬁcient background. Puriﬁcation of GAPDH from this strain
y afﬁnity chromatography followed by factor Xa cleavage yielded
nUng-freeGAPDHsample.When this samplewas used as a source
f UDG activity in the Endo IV-coupled assay, the 20-mer cleavage
roduct was not observed (Fig. 7C, lanes 5 and 6), indicating that
. coli GAPDH does not display UDG activity. Thus, the UDG activ-
ty observed with GAPDH samples puriﬁed from E. coli strains with
n intact ung gene was due to chromosome-encoded UDG. In addi-
ion, these results indicated interaction between GAPDH and thehemistry & Cell Biology 60 (2015) 202–212 209
UDG enzyme. To test whether interaction between the two pro-
teins requires Endo IV, recombinant GST-GAPDH was expressed
in an Endo IV deﬁcient strain (MG1655 nfo::cm), puriﬁed by afﬁn-
ity chromatography, followed by factor Xa cleavage as described
above, and used as a source of UDG activity in the Endo IV-coupled
assay (Fig. 7C, lanes 7 and 8). As GAPDH does not display UDG
activity, formation of the 20-mer product (Fig. 7, lane 8) may be
attributed to the presence of chromosome-encoded UDG. Pull-
down experiments were then performed to conﬁrm interaction
between GAPDH and UDG. Recombinant His6-UDG was expressed
in thenfomutant aswell as in its parentalwild-type strainMG1655.
Each batch of recombinant UDG protein was applied to a Ni2+-NTA
resin and the presence of chromosome-encoded GAPDH in the elu-
tion fractions was analyzed by western blot (Fig. 5B). Co-elution of
GAPDH with UDG in both cases conﬁrmed the interaction between
these proteins and indicated that this interaction does not depend
on Endo IV.
The presence of the 20-mer product in the reactions performed
with GAPDH in the absence of added Endo IV (Fig. 7A, lanes 5, 7 and
9) indicated that the GAPDH preparation also contained associated
Endo IV. This ﬁnding was compatible with results presented above
showing co-elution of both proteins in pull-down experiments in
different afﬁnity supports (Figs. 5A and 6). Immunodetection of
GAPDH in the elution fractions of pull-down experiments per-
formed using as bait His6-Endo IV expressed in the mutant strain
MG1655 ugn::kan (not shown) indicated that UDG is not required
for GAPDH–Endo IV interaction.
4. Discussion
Moonlighting functions related with DNA repair have been
reported for human GAPDH. This protein translocates to the
nucleus when cells are challenged with oxidative stress condi-
tions (Dastoor and Dreyer, 2001) and has been found associated
with damaged DNA in cells treated with chemotherapeutic agents
(Krynetski et al., 2003). In addition, human GAPDH interacts with
the endonuclease APE1, an essential enzyme for the repair of AP
sites. This interaction contributes to reactivation of oxidized forms
of APE1 generated as a consequence of aerobic metabolism (Azam
et al., 2008).
The study presented here in E. coli implicates GAPDH in the
repair of DNA lesions in bacteria. Several lines of evidence support
this conclusion: (i) increased sensitivity of GAPDH-deﬁcient cells to
BM or MMS, (ii) ﬁlamentous growth of GAPDH-deﬁcient cells upon
incubation with BM or MMS, as well as accumulation of unrepaired
DNA lesions after recovery fromMMS-damage, (iii) increased num-
ber of spontaneous AP sites and spontaneous mutation frequencies
in gapA mutants versus wild-type isogenic strains and (iv) interac-
tion of GAPDH with SSB and proteins of the BER pathway, namely
UDG and Endo IV.
The ﬁlamentous growth of gapA null mutants and GAPDH-
silenced cells treatedwith BMorMMS is a sign of the SOS response.
As stated above, AP sites are BER intermediates formed in MMS-
treated bacterial cells after excision of methylated bases by DNA
glycosylases. These abasic sites are also directly generated by the
action of BM on DNA. There is evidence that accumulation of AP
sites triggers the SOS response. When the repair of alkylated bases
by the BER system is insufﬁcient, other pathways connected to the
SOS response, like homologous recombination, contribute to DNA
repair (Janion et al., 2003). Thus, ﬁlamentous growth of GAPDH-
deﬁcient cells is consistent with the inability of these cells to
efﬁciently repair the AP sites generated by either genotoxic agent.
Indeed, results fromalkalineDNAdegradation assays point tomore
unrepaired lesions in thegenomicDNAof thegapAmutant than in
the parental strain after 3-h recovery from extensiveMMSdamage.
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Fig. 7. GAPDH does not display UDG activity. (A) Analysis of the UDG activity of puriﬁed GAPDH. The 40-mer duplex DNA substrate containing a U-G mismatch (U19.G)
was incubated with commercial E. coli UDG (Ung) as a positive control of the UDG activity (lanes 3 and 4) or with 10g of the indicated puriﬁed GAPDH variants (lanes
5–10). These GAPDH variants were expressed and puriﬁed from strain MC4100gapA using the GST fusion system recognition sites for factor X cleavage. When indicated,
commercial Endo IV was added to the reaction mixture. Shown are the controls, substrate alone (lane 1) or incubated only with Endo IV (lane 2). The arrows indicate positions
of the 40-mer substrate and the 20-mer product. (B) Inhibition of the GAPDH-associated UDG activity by Ugi. The substrate was incubated with commercial UDG (lanes 3 and
5) or with 10g of puriﬁed GAPDH (lanes 2 and 4) in the absence or presence of the inhibitor Ugi. Commercial Endo IV was added to all reactions. The control corresponding
to the substrate alone (lane 1) is shown. (C) GAPDH-associated UDG activity is due to accompanying chromosome-encoded Ung. The substrate was incubated with 10g of
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ith commercial UDG (lanes 9 and 10) are shown.
Repair of AP sites depends on the activity of AP-endonucleases.
. coli has two AP-endonucleases, Exo III and Endo IV. Exo III is
onstitutively expressed while Endo IV is inducible by oxidative
tress. These enzymes are structurally unrelated and belong to dif-
erent families ofAP-endonucleases. TheExo III familymembers are
resent in all kingdoms, whereas Endo IV members are expressed
nly in lowerorganisms (Daley et al., 2010). As stated above, human
APDH interacts with and modulates the activity of APE1, which
isplays 52% similarity with E. coli Exo III. Results of our pull-down
xperiments indicate that E. coli GAPDH interacts with Endo IV but
ot with Exo III. Human APE1 has 39 amino acid residues at the N-
erminus that are not present in Exo III. This difference may affect
rotein interactions. As Endo IV does not undergo redox reaction as
oes APE1, the role of GAPDH in repairing oxidized Endo IV seems
ot plausible. Interaction between GAPDH and Endo IV does not
mply that GAPDHmodulates Endo IV, butmay serve to assist other
NA repairing activities.
Although Exo III is considered the major AP-endonuclease in
. coli (Cunningham et al., 1986), several studies show relevant
ontribution of Endo IV in repairing DNA damage caused by some
enotoxic agents. In this regard, nfo mutants are hypersensitive to
M and t-butyl hydroperoxide, and mildly hypersensitive to MMS
ndmitomycin (Cunninghamet al., 1986). Endo IValso signiﬁcantly
ontributes to the repair of AP sites following endogenous DNA
amage, which occurs continuously in nature. AP sites are both
utagenic and cytotoxic, thus DNA repair mechanisms are essen-
ial to correct replication and transcription. Studies performedwiths MG1655 ung:kan (deﬁcient in UDG) and MG1655 nfo::cm (deﬁcient in Endo IV).
rresponding to the substrate alone (lane 1) as well as the positive reaction control
single nfo or xth mutants showed a greater contribution of Endo IV
than Exo III in preventing transcriptional mutations caused by the
formation of AP sites (Clauson et al., 2010). Here, we provide evi-
dence that the ability to repair spontaneous AP sites is reduced
in GAPDH-deﬁcient cells. During aerobic exponential growth, the
gapA null mutant displays a 1.5-fold increase in spontaneous AP
sites when compared to the wild-type strain. Consistently, the fre-
quency of spontaneous mutation was higher in this mutant. The
about 4.7-fold increase in the spontaneous mutation frequency
estimated in this study for strain MC4100 gapA is similar to the
values reported for E. coli ung or nfo single mutants, which were
5.1- and 4.6-fold, respectively (Barthi and Varshney, 2010; Sikora
et al., 2010).
One of the ﬁrst moonlighting functions associated with human
GAPDH was its activity as uracil–DNA glycosylase (Meyer-Siegler
et al., 1991). Later studies conducted to purify and characterize two
different humanuracil-DNAglycosylases (UDG1andUDG2) did not
detect such activity associated with human GAPDH. Instead, this
activity was attributed to contaminating proteins present in the
commercial erythrocyte GAPDH sample, probably UDG1 or UDG2
(Caradonna et al., 1996). Likewise, our results rule out UDG activ-
ity in E. coli GAPDH. The uracil-removing activity detected with
our GAPDH preparations (either the wild-type protein or the Cys
mutated variants) may be attributed to the chromosome-encoded
UDG (ung gene product) as this activity was no longer identiﬁed
when the recombinant GAPDH protein was expressed in an ung
mutant background. Overall, these results indicate that GAPDH
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s strongly associated with UDG enzymes both in humans and
n bacteria. On the other hand, the two commercial sources of
. coli UDG used here (Sigma or New England Biolabs) contained an
P-endonuclease accompanying activity, thus indicating a strong
inding afﬁnity between the enzyme that removes uracil fromDNA
nd the nuclease that repairs the AP site. Based on our results, this
P-endonuclease could be Endo IV.
The reported interaction between GAPDH and Gph suggested
nvolvement of GAPDH in protein complexes that repair BM-
nducedDNA lesions (Ferreira et al., 2013). Our results here conﬁrm
hat E. coli GAPDH is required for efﬁcient repair of AP sites through
he BER pathway. In this context, its interaction with Endo IV and
GD indicates that GAPDH is a component of protein complexes
edicated to the maintenance of genomic DNA integrity.
Since Endo IV displays additional roles not shared by Exo III, the
nteraction of GAPDHwith Endo IV implicates GAPDH in other DNA
epair pathways like the nucleotide incision repair (NIR) pathway.
ndo IV contributes to this pathway by processing a broad range
f DNA lesions like those caused by ionizing radiation damage
n cytosine residues under either oxidative or anoxic conditions
Ishchenko et al., 2004; Daviet et al., 2007). Our study has also
hown interaction of GAPDH with SSB, an essential protein that
nteracts with single-stranded DNA preventing the formation of
econdary structures and its degradation by nucleases (Greipel
t al., 1987; Dabrowski et al., 2002; Furukohri et al., 2012). SSB
as a crucial role in the recruitment of proteins involved in DNA
eplication and repair, such as homologous recombination and
OS response (Furukohri et al., 2012). In fact, E. coli ssb mutants
re highly sensitive to several alkylating agents, including MMS
Greenberg et al., 1974, 1975). Thus, interaction of GAPDH with
SB may recruit GAPDH to the DNA repair sites. The ﬁlamentous
rowth of GAPDH-deﬁcient cells and the interaction of GAPDH
ith SSB point toward GAPDH as a component of protein com-
lexes involved in DNA repair pathways activated under profuse
NA damage.
The functional role of GAPDH in DNA repair is not yet known.
s a component of protein complexes, GAPDH may act as a scaf-
old protein or may have a role in modulating the activity of other
rotein components.
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